Resveratrol researcher fingered in sweeping misconduct case

The University of Connecticut, in what clearly seems like an attempt to get ahead of damaging news, has announced an “extensive” investigation into research misconduct involving one of its scientists, Dipak K. Das.
...
One area of interest for Das, a government-funded professor of surgery and director of the Cardiovascular Research Center, has been resveratrol, a substance in red wine that has allegedly been linked to improved cardiac health.
...
Das’ work has been influential. Thirty of his papers have been cited more than 100 times, according to Thomson Scientific’s Web of Knowledge. One, in Toxicology, has been cited 349 times, while another, in Free Radical Biology, has been cited 230.
...
Das appears to have had a relationship with a Las Vegas resveratrol maker called, unsurprisingly, Longevinex. The company has promoted his research, and Das also shows up in a lengthy video touting the nutrient as the next aspirin. The infomercial is guided by an “investigative reporter” named Gailon Totheroh, who is affiliated with the Christian Broadcasting Network.
...
But at least one resveratrol expert says the damage from the fraud on this particular area of research will be minimal. Nir Barzilai, of Albert Einstein College of Medicine, said he’d heard of Das but never met him. He noted that most of his admittedly vast list of publications seem to be in lower-impact factor journals, and that the field is strong: "There are many investigators who are working on resveratrol. That doesn’t mean we know the whole truth. But Rome wasn’t built on Dr. Das."